Global Cancer Therapeutics Market Outlook
Global Cancer Therapeutics Market Outlook
RELEASE DATE
28-Oct-2005
28-Oct-2005
REGION
Global
Global
Research Code: F404-01-00-00-00
SKU: HC01452-GL-MR_05946
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC01452-GL-MR_05946
Description
The Global Cancer Therapeutics Market is a fast growing market that is relying heavily on new drugs. The total therapeutic market is expected to grow from $23.1 billion in 2004 to $60.6 billion in 2011. The targeted therapy segment is providing the growth of the entire market with an expected compound annual growth rate of 24.1 percent for 2004-2011.
Table of Contents
Introduction
- Introduction
- Disclaimer
- Certification
- Contents
- Top 15 Growth Cancer Therapeutics
Market Overview
- Contents
- Research Scope and Methodology
- Abreviations
- Segmentation
- Targeted Therapy Segments
- Targeted Therapy Definitions
- Summary of Findings
- Market Drivers (1)
- Market Drivers (2)
- Challenges and Strategies (1)
- Challenges and Strategies (2)
- Challenges and Strategies (3)
- Challenges and Strategies (4)
- Challenges and Strategies (5)
Total Market Forecasts
- Contents
- Total Market Forecasts
- Total Market Forecasts by Therapeutic Class
- US Forecasts by Therapeutic Class
- Ex US Forecasts by Therapeutic Class
- Cytotoxic Therapy Forecasts
- Hormone Therapy Forecasts
- Targeted Therapy Forecasts
- Global Market Share Analysis
- US Market Share Analysis
- Ex US Market Share Analysis
NSCLC
- Contents
- Disease Overview
- Epidemiology Trends
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Breast Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Hormone Treatment Diagram
- Metastatic Treatment Diagram
- Revenue Forecasts
- Drug Development
Colorectal Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Prostate Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Top 15 Growth Therapeutic Cancer Drugs (Overview; Indications Development and Forecasts)
- Contents
- Top 15 Growth Therapeutic Cancer Drugs
- Rituxan/MabThera
- Taxotere
- Gleevec/Glivec
- Eloxatin
- Gemzar
- Herceptin
- Zometa
- Casodex
- Arimidex
- Avastin
- Camptosar/Campto
- Temodar/Temodal
- Xeloda
- Femara
- Erbitux
Recent Filings and Approvals
- Contents
- Recent Filings and Approvals
Key Late-Stage Pipeline Drugs
- Contents
- Key Late-Stage Pipeline Drugs
Awards
- Contents
- Frost & Sullivan Awards
- Company of the Year
- Product Innovation of the Year
- Product-Line/Pipeline Strategy of the Year
- Entrepreneurial Company of the Year
- Business Development Strategy of the Year
Frost & Sullivan Capabilities
- Contents
- Our Capabilities I
- Our Capabilities II
- Our Consulting Clients
- Growth Consulting
- Growth Consulting Process
- Growth Consulting Deliverables
- Growth Partnership Service
- Growth Partnership Services Platform
Related Research
Popular Topics
The Global Cancer Therapeutics Market is a fast growing market that is relying heavily on new drugs. The total therapeutic market is expected to grow from $23.1 billion in 2004 to $60.6 billion in 2011. The targeted therapy segment is providing the growth of the entire market with an expected compound annual growth rate of 24.1 percent for 2004-2011.
No Index | No |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | F404-01-00-00-00 |
Is Prebook | No |